Active ingredientTelavancinCat. No. P-T038-001CAS 372151-71-8Family · Pharmaceutical analytical standards
Telavancin
A semi-synthetic lipoglycopeptide antibiotic derived from vancomycin, active against Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA); in the United States it was approved in 2009 for complicated skin infections and in 2013 for hospital-acquired pneumonia. This family brings together the active ingredient and nitrosamines.
Did you know?It descends from vancomycin, isolated in 1953 from a bacterium found in a soil sample from a forest in Borneo; unlike its parent molecule it strikes in two ways, blocking the bacterial cell wall and depolarising the membrane.
Go to the active ingredient →Active ingredientTelavancinCat. No. P-T038-001CAS 372151-71-8
Active ingredientTelavancin HClCat. No. P-T038-002CAS 560130-42-9
NitrosamineN-Nitroso Telavancin 1Cat. No. P-T038-003
NitrosamineN-Nitroso Telavancin 2Cat. No. P-T038-004
NitrosamineN-Nitroso Telavancin 3Cat. No. P-T038-005
NitrosamineN-Nitroso Telavancin 4Cat. No. P-T038-006No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.